Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (431-440 of 762) with videos related to

Pageof 77
Sort By:
Diabetes|March 2, 2002
Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cellsKaren Moens, Veerle Berger, Jung-Mo Ahn, et al.
Journal of Medicinal Chemistry|January 7, 1994
Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptorsH Bartosz-Bechowski, P Davis, T Zalewska, et al.
International Journal of Peptide and Protein Research|July 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|December 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|August 6, 1984
alpha-MSH analogues and adrenal zona glomerulosa functionG P Vinson, B J Whitehouse, A Bateman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Structure-activity analysis of five constrained somatostatin like peptides with opioid antagonist propertiesW S Wire, J T Pelton, W Kazmierski, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouseP J Horan, B R de Costa, K Rice, et al.
Current Pharmaceutical Design|August 12, 2016
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke TreatmentMohammad Rashedul Islam, Li Yang, Yeon Sun Lee, et al.
Journal of Medicinal Chemistry|September 1, 1982
Comparative biological activities of highly potent active-site analogues of alpha-melanotropinT K Sawyer, V J Hruby, B C Wilkes, et al.
Pageof 77

Showing results (431-440 of 762) with videos related to

Sort By:
Pageof 77
Diabetes|March 2, 2002
Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cellsKaren Moens, Veerle Berger, Jung-Mo Ahn, et al.
Journal of Medicinal Chemistry|January 7, 1994
Cyclic enkephalin analogs with exceptional potency at peripheral delta opioid receptorsH Bartosz-Bechowski, P Davis, T Zalewska, et al.
International Journal of Peptide and Protein Research|July 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
International Journal of Peptide and Protein Research|December 1, 1994
Delta opioid receptor selective ligands; DPLPE-deltorphin chimeric peptide analoguesA Misicka, A W Lipkowski, R Horvath, et al.
Life Sciences|August 6, 1984
alpha-MSH analogues and adrenal zona glomerulosa functionG P Vinson, B J Whitehouse, A Bateman, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
Structure-activity analysis of five constrained somatostatin like peptides with opioid antagonist propertiesW S Wire, J T Pelton, W Kazmierski, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouseP J Horan, B R de Costa, K Rice, et al.
Current Pharmaceutical Design|August 12, 2016
Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke TreatmentMohammad Rashedul Islam, Li Yang, Yeon Sun Lee, et al.
Journal of Medicinal Chemistry|September 1, 1982
Comparative biological activities of highly potent active-site analogues of alpha-melanotropinT K Sawyer, V J Hruby, B C Wilkes, et al.
Pageof 77